
Aspira Women's Health AWH
Annual report 2025
added 04-01-2026
Aspira Women's Health Depreciation & Amortization 2011-2026 | AWH
Annual Depreciation & Amortization Aspira Women's Health
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 K | 92 K | 264 K | 302 K | 265 K | 333 K | 675 K | 786 K | 723 K | 291 K | 141 K | 72 K | 86 K | 77 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 786 K | 72 K | 301 K |
Quarterly Depreciation & Amortization Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 K | 13 K | - | - | - | 29 K | - | - | - | 70 K | - | 195 K | 128 K | 64 K | - | 238 K | 172 K | 90 K | - | 178 K | 114 K | 56 K | - | 276 K | 215 K | 124 K | - | 527 K | 370 K | 186 K | - | 599 K | 401 K | 202 K | - | 523 K | 323 K | 147 K | - | 197 K | 113 K | 53 K | - | 93 K | 58 K | 27 K | - | 55 K | 39 K | 21 K | - | 64 K | 42 K | 21 K | - | 55 K | 34 K | 15 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 599 K | 13 K | 154 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
321 M | $ 115.48 | 0.82 % | $ 35.1 B | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.2 | -0.61 % | $ 175 M | ||
|
Biodesix
BDSX
|
5.77 M | $ 15.07 | 2.1 % | $ 1.95 B | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Castle Biosciences
CSTL
|
16 M | $ 24.84 | -0.84 % | $ 690 M | ||
|
DarioHealth Corp.
DRIO
|
307 K | $ 8.4 | 3.7 % | $ 33.5 M | ||
|
BioNano Genomics
BNGO
|
9.53 M | $ 1.2 | 0.84 % | $ 6.53 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 173.89 | -0.58 % | $ 8.62 B | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
DexCom
DXCM
|
252 M | $ 62.22 | -0.24 % | $ 24.3 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 16.82 | 2.31 % | $ 509 M | ||
|
Biomerica
BMRA
|
87 K | $ 2.17 | -0.91 % | $ 4.98 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Celcuity
CELC
|
167 K | $ 112.63 | -0.27 % | $ 5.27 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 198.02 | 0.17 % | $ 22 B | ||
|
Guardant Health
GH
|
39.7 M | $ 93.83 | 2.94 % | $ 11.8 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 76.1 | 0.53 % | $ 5.14 B | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 498.34 | 1.81 % | $ 14.4 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.96 | 5.82 % | $ 8.67 M | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 259.94 | -1.11 % | $ 26 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 114.19 | 2.49 % | $ 9.42 B | ||
|
IDEXX Laboratories
IDXX
|
145 M | $ 569.55 | 0.87 % | $ 45.8 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.41 | 0.21 % | $ 2.04 B | ||
|
Illumina
ILMN
|
354 M | $ 127.38 | 0.59 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
1.14 B | $ 173.26 | 0.5 % | $ 29.8 B | ||
|
Pacific Biosciences of California
PACB
|
13 M | $ 1.34 | -0.74 % | $ 402 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 273.72 | 0.36 % | $ 22.8 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.75 | 3.49 % | $ 440 M | ||
|
Sotera Health Company
SHC
|
94.9 M | $ 14.96 | 0.61 % | $ 4.25 B | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.0 | 3.23 % | $ 1.02 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 17.16 | -1.04 % | $ 384 M |